Qatar Biomedical Research Institute (QBRI) creates programs in partnership with local and international research bodies. Established to commercialize promising biotechnologies, QBRI sets out to deliver health benefits to local patients and to create new business ventures.

The I-Stem Institute integrates three different activities: a basic biological research laboratory, a technological platform for development and application, and a biological and technological resource centre. To each one of these main types of activity correspond specific forms of organization, ways of financing and different partnerships, which will be created gradually and in a coordinated way to ensure complementarity. - (Read more)

EuroStemCell comprises investigators from across Europe involved in requirements to take stem cell technology to the clinic. Includes meetings, introduction to key personnel, partner institutions, and projects coordinated from Edinburgh, Scotland. - (Read more)

A Canadian association that brings together scientists, clinicians, and ethicists to investigate the therapeutic potential of stem cells. Includes articles about research in field being currently conducted. - (Read more)

The United Kingdom National Stem Cell Network (UKNSCN) was established in July 2006 as an independent national body for the promotion of research across the sub-disciplines of stem cell science and to act as the national focal point for disseminating information about UK stem cell research to overseas researchers, the general public and the media.
Its central mission is the promotion of research activities and events at the national level which help to speed the translation of basic stem cell research into therapeutic applications in the control of degenerative diseases such as Alzheimer’s, Parkinson’s and diabetes. - (Read more)

Aims to bring together businesses and communities involved in stem cell research, tissue engineering and regenerative medicine. Includes details of meetings, links to participants and contacts in London, UK. - (Read more)

Collaboration founded in 2003, for different research groups focusing on applications in for regenerative medicine. Includes publication list, announcements, contacts for members around Norway. - (Read more)

Nichi-In Centre for Regenerative Medicine (NCRM) is an institute carrying out research, training (both scientists and physicians) clinical applications-protocol development in regenerative medicine based on cell therapeutics, with emphasis on stem cells, Progenitor cells, precursor cells and autologous cells with regenerative capability and to take them to en mass clinical application, while maintaining the highest ethical and scientific values of international standards. - (Read more)

The International Consortium of Stem Cell Networks is a ‘network of networks’ that aims to unify international efforts to accelerate opportunities to make stem cell therapy a reality for a broad range of debilitating diseases.

The mission of RIKEN is to conduct comprehensive research in science and technology (excluding only the humanities and social sciences) as provided for under the "RIKEN Law," and to publicly disseminate the results of its scientific research and technological developments. RIKEN carries out high level experimental and research work in a wide range of fields, including physics, chemistry, medical science, biology, and engineering, covering the entire range from basic research to practical application. - (Read more)

The International Cellular Medicine Society is a global non-profit that represents over 1,000 physicians, researchers and patients from over 35 countries on 6 continents. They are dedicated to patient safety and education in the medical use of adult stem cells.

Through the publication of Guidelines for the collection, processing and re-implantation of stem cells of stem cells, the ICMS provides best practice standards for physicians and clinicians worldwide.

Through the management of a patient reported Treatment Registry, the ICMS provides long term, proactive outcomes follow up and complications tracking for stem cell patients.

If you are a patient, physician or scientist, please Join the ICMS. The ICMS is a volunteer driven organization. Membership is free and your voice is important. - (Read more)

Scotland has an outstanding reputation for scientific excellence, with its work in the life science field highly regarded world wide. In recognition of this, the Scottish Government has indentified the sector as a priority industry. Under the umbrella of life sciences, stem cell research is one of Scotland’s shining examples of academic distinction, as backed up by a recent Edinburgh Science Triangle (EST) market analysis

The country as a whole ranked 1st in the world for stem cell research based on citation impact in 2007 (ScienceWatch). In 2008 Scotland received a larger proportion of UK Clinical Medicine funding than London, Cambridge and Oxford - 7.4%>6.7%, 1.2%, 1.8% (Source: RAE). From 1997 – 2007, the University of Edinburgh was ranked 3rd in the world for Stem Cells based on citation impact (source: ScienceWatch) and the University of Glasgow ranked 4th in Europe for Clinical Medicine.

The North East England Stem Cell Institute (NESCI) is a collaboration between Durham and Newcastle Universities, the Newcastle Hospitals NHS Foundation Trust and other partners, including the Centre for Life in Newcastle.

One of our primary aims is the development of new stem cell treatments and providing research tools for drug discovery. To do, this we have strong links with a range of academic, clinical, commercial and other partners. We have benefitted from our partners' support and we have state of the art laboratories and specialist facilities.

We are keen to encourage public debate and commercial partnering in this area - find out more about our work.

The Genome Institute of Singapore is a unique place for scientific discovery. We believe that a future in biology lies in the fusion of highly comprehensive and massively parallel genomic and computational approaches with cell and medical biology. Therefore, we seek the integration of technology and biology towards answering questions of medical importance.

We will support this vision by creating a social culture that encourages open communication, fluid organizational structures and teamwork but without diminishing individual effort.

Our approach is strategic and is based on long-term scientific and social objectives. I am very pleased to be leading this noble effort, excited about our future and delighted with the colleagues who have decided to join us on this adventure.